Schroeter appeared at the base of IBM's cloud-based analytics platform Watson and touted how the tech giant constructs solutions to their clients' most difficult problems. Watson is the most recent instrument to achieve that goal, he said, and represents several hundred patents.
IBM currently operates a $17 billion analytics business, and the company is integrating Watson into that business.
Watson's first task will be health care, and Schroeter said the system can scan more than 12 million medical journal articles and issue accurate diagnoses in a matter of hours compared to weeks. Watson then releases that information to doctors on an iPad. Furthermore, Schroeter said Watson can identify patterns that humans cannot because it scans all data rather than subsets of data.
Finally, the CFO said IBM will soon task Watson with analyzing social media feeds to identify trends and make predictions as it scans millions of posts worldwide in multiple languages.
Insight from TheStreet's Research Team
Jim Cramer commented on IBM in a recent post on Real Money. Here's what he had to say about the stock:
Can Watson move the needle for IBM?
I don't think anyone believes it can or will. It's only a small portion of a large company. It has some terrific uses, but mostly in health care from what I saw, although that's a giant category. And there are competitors, including Metamind.io, a start-up that has a very compelling bead on the social media information that Watson reads.
But Watson's less of an earnings per share play than it is a metaphor. You see, unlike most companies in the situation IBM finds itself in (with a slowly declining core business), IBM is working to offset that with a rapidly advancing cloud-based effort that will make sense of a tsunami of big data, help interpret it and more importantly, help predict it.
I think Watson, basically, is a fantastic sales call. As someone who sold at Goldman Sachs and taught selling, I would love to be able to demo Watson for people. I would love to show a company the capabilities that Watson has to figure out ways to make a business better.
Want more information like this from Jim Cramer BEFORE your stock moves? Learn more about Real Money now!
Separately, TheStreet Ratings team rates INTL BUSINESS MACHINES CORP as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate INTL BUSINESS MACHINES CORP (IBM) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, growth in earnings per share and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself."
You can view the full analysis from the report here: IBM Ratings Report